别名:Leucine-rich repeats and immunoglobulin-like domains protein 3, LIG-3, LRIG3, LIG3应用:WB
反应种属:Human
规格:50μl/100μl
Description |
---|
May play a role in craniofacial and inner ear morphogenesis during embryonic development. May act within the otic vesicle epithelium to control formation of the lateral semicircular canal in the inner ear, possibly by restricting the expression of NTN1 (By similarity). |
Specification | |
---|---|
Aliases | Leucine-rich repeats and immunoglobulin-like domains protein 3, LIG-3, LRIG3, LIG3 |
Entrez GeneID | 121227 |
Swissprot | Q6UXM1 |
WB Predicted band size | 123.4kDa |
Host/Isotype | Rabbit IgG |
Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
Species Reactivity | Human |
Immunogen | This LRIG3 antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 23-54 amino acids from human LRIG3. |
Application | |
---|---|
WB | 1/2000 |
![]() |
All lanes : Anti-LRIG3 Antibody (N-Term) at 1:2000 dilution Lane 1: Hela whole cell lysate Lane 2: HepG2 whole cell lysate Lane 3: 293T/17 whole cell lysate Lysates/proteins at 20 µg per lane. Secondary Predicted band size : 123 kDa Blocking/Dilution buffer: 5% NFDM/TBST. |
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的,不可用于人类或动物的临床诊断或治疗,非药用,非食用。
暂无评论
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的,不可用于人类或动物的临床诊断或治疗,非药用,非食用。
发表回复